Paper Review Records
All Paper Review Records
7 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
357
days
CAR-T cell therapy for multiple myeloma: An update on the current state and future potential
Authors
Prateek Pophali; Jacalyn Rosenblatt; David AviganShow moreShow less
Affiliations
Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA; Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USAShow moreShow less
77
days
The correlations among racial/ethnic groups, hypertriglyceridemia, thrombosis, and mortality in hospitalized patients with COVID-19
Authors
Maya Rodriguez; Wen Dai; Hayley Lund; Kristen Osinski; Ziyu Zhang; Roy Silverstein; Ze ZhengShow moreShow less
Affiliations
1. Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, WI, USA; 2. Diversity Summer Health-Related Research Education Program (DSHREP), Medical College of Wisconsin, Milwaukee, WI, USA; 3. College of Arts and Sciences, Marquette University, Milwaukee, WI, USA; 4. Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA; 5. Clinical & Translational Science Institute (CTSI) Biomedical Informatics, Medical College of Wisconsin, Milwaukee, WI, USAShow moreShow less
31
days
Flow cytometry in lymphoma diagnosis and prognosis: Useful?
Authors
Maryalice Stetler-StevensonShow moreShow less
Affiliations
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 2N-108, Mail Stop 1500, Bethesda, MD 20892, USAShow moreShow less
28
days
Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia
Authors
Miguel A Sanz; Guillermo Martı́nShow moreShow less
Affiliations
Haematology Service, University Hospital La Fe, Valencia, SpainShow moreShow less
28
days
Treatment of older adults with acute promyelocytic leukaemia
Authors
Pierre FenauxShow moreShow less
Affiliations
Department of Hematology, Paris XIII University, France and Hôpital Avicenne, Bobigny 93000, FranceShow moreShow less
393
days
All-trans retinoic acid in acute promyelocytic leukaemia
Authors
Giuseppe AvvisatiShow moreShow less
Affiliations
Hematology, University Campus Bio-Medico, Via Emilio Longoni 83, Roma 00159, ItalyShow moreShow less
FAQ
How long does BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY take to review a manuscript?
As of 2026-11-19, CrushSCI has 7 complete review records for BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. The fastest paper went from submission to acceptance in 28 days (Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia, received 2003-02-01, accepted 2003-03-01); the slowest took 393 days. The average is 186.7 days and the median is 77 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
